IL6 and Insulin resistance: (2) HUCMSCs mitigate insulin resistance (IR)by regulating adipocyte metabolism, which includes reducing the release of inflammatory factors such as TNF-α and IL-6, and by enhancing hepatic glucose and lipid metabolism, promoting glycogen synthesis while inhibiting gluconeogenesis [37].